ATH-1017

· LeonaBio

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ATH-1017, covering 2023-06-12 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease [Phase 2, Phase 3]